• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

coronavirus

Here at MassDevice — medtech's online business journal — we're covering news about the coronavirus (COVID-19) pandemic daily. Here is the latest about coronavirus and the medical device industry, regulatory changes related to the pandemic, new tests for the virus, vaccine development, and much more.

PharmaJet partner touts interim safety results for needle-free COVID-19 vaccine

February 15, 2022 By Sean Whooley

PharmaJet announced today that its partner, Technovalia, reported positive interim safety results from a needle-free COVID-19 vaccine trial. Golden, Colorado–based PharmaJet’s needle-free injection systems are being studied with Covigen, a DNA-based vaccine developed by French-Thai pharmaceutical company BioNet-Asia in collaboration with Melbourne, Australia-based Technovalia. Enrollment for the trial began in June 2021. Get the full story […]

Filed Under: Clinical Trials, Drug Pumps, Drug-Device Combinations, Featured, News Well, Pharmaceutical Tagged With: coronavirus, COVID-19, PharmaJet

FDA resumes inspections in U.S. as omicron cases decline

February 7, 2022 By Sean Whooley

The FDA announced that it is set to resume conducting domestic surveillance inspections after a brief postponement. In December, the agency confirmed temporary changes to inspectional activities due to COVID-19 as the omicron variant of the virus led to surges across the world. The FDA implemented the changes in the U.S. on Dec. 29, 2021, […]

Filed Under: Featured, Food & Drug Administration (FDA), News Well, Regulatory/Compliance Tagged With: coronavirus, COVID-19, FDA

Thermo Fisher launches PCR testing platform that detects COVID-19 pathogens in the air

February 7, 2022 By Sean Whooley

Thermo Fisher Scientific (NYSE:TMO) announced today that it launched a new rapid environmental COVID-19 diagnostic platform. Waltham, Massachusetts-based Thermo Fisher designed its Renvo rapid in-air pathogen PCR test for detecting the virus on air samples collected through the company’s Thermo Scientific AerosolSense Sampler. According to a news release, the company designed the test for environmental […]

Filed Under: Business/Financial News, Diagnostics, Featured, Genomics/Molecular Diagnostics, News Well Tagged With: coronavirus, COVID-19, Thermo Fisher Scientific

Labcorp launches on-demand platform for purchasing diagnostics

February 4, 2022 By Sean Whooley

Labcorp (NYSE:LH) announced today that it launched Labcorp OnDemand to ease the experience of using the company’s diagnostics. Burlington, North Carolina-based Labcorp’s Labcorp OnDemand provides a platform on which individuals can purchase tests online, collect samples in their own home or schedule test appointments at one of Labcorp’s 2,000 patient service centers. The OnDemand platform […]

Filed Under: Business/Financial News, Diagnostics, Featured, Genomics/Molecular Diagnostics Tagged With: coronavirus, COVID-19, LabCorp

Could nasal vaccines be the next big weapon against COVID-19?

February 3, 2022 By Sean Whooley

Because of the way they provide protection, nasal vaccines could be the best long-term way to prevent COVID-19 infection, according to experts cited in The New York Times. The Times reported that India-based Bharat Biotech, which has the Covaxin COVID-19 vaccine authorized in India and elsewhere, has an experimental COVID-19 nasal vaccine that may offer […]

Filed Under: Clinical Trials, Drug-Device Combinations, Featured, Pharmaceutical, Respiratory Tagged With: Bharat Biotech, coronavirus, COVID-19

Study bolsters case that vaccines protect against long-COVID

February 1, 2022 By Brian Buntz

It may be too soon to know how often the omicron variant is associated with so-called long-COVID, but research from the Leavitt Partners’ COVID-19 Patient Recovery Alliance confirms that vaccination protects against the condition.  Those who received at least one authorized COVID-19 vaccine dose before diagnosis were between seven and 10 times less likely to […]

Filed Under: Blog, Featured, Pharmaceutical Tagged With: coronavirus, COVID-19, COVID-19 Patient Recovery Alliance

FDA fully approves Moderna’s COVID-19 vaccine

January 31, 2022 By Sean Whooley

Moderna (NSDQ:MRNA) announced today that it received full FDA approval of the biologics license application for its COVID-19 vaccine. FDA’s approval for the company’s Spikevax mRNA COVID-19 vaccine covers the prevention of the virus in individuals aged 18 years or older. Moderna submitted for full FDA approval back in June 2021 and becomes the second […]

Filed Under: Business/Financial News, Featured, Food & Drug Administration (FDA), News Well, Pharmaceutical, Regulatory/Compliance Tagged With: coronavirus, COVID-19, FDA, Moderna

Super bright X-rays offer insights into how COVID-19 damages the lungs

January 31, 2022 By Chris Newmarker

An international team has used super-bright X-rays to capture intricate details of COVID-19 lung damage — and much more. Their technique — called Hierarchical Phase-Contrast Tomography (HiP-CT) — relies on X-rays from the European Synchrotron Research Facility particle accelerator in Grenoble, France. Following its Extremely Brilliant Source upgrade (ESRF-EBS), European Synchrotron can produce X-rays 100 […]

Filed Under: Diagnostics, Featured, Imaging, Research & Development, Respiratory Tagged With: coronavirus, COVID-19, European Synchrotron Research Facility, University College London

How Phillips-Medisize helped Sotech Health develop a breath analyzer for COVID-19

January 27, 2022 By Chris Newmarker

Medtech contract manufacturing giant Phillips-Medisize used its human-factors product design expertise to help startup Sotech Health create what the companies claim is a breath sensor system that can detect COVID-19 in less than 30 seconds. Dallas-based Sotech Health has submitted the device to the FDA for an emergency use authorization. It’s also seeking regulatory nods in Canada, […]

Filed Under: Contract Manufacturing, Diagnostics, Digital Health, Featured, News Well, Outsourcing Tagged With: coronavirus, COVID-19, Phillips-Medisize, Sotech Health

Intuitive posts Street-beating Q4 despite COVID-19-related procedure disruptions

January 21, 2022 By Sean Whooley

Intuitive (Nasdaq: ISRG) shares are down today despite fourth-quarter results that topped the consensus forecast. Despite Street-beating results, the Sunnyvale, California–based robotic surgery technology developer also reported that COVID’s omicron wave is affecting procedure volumes. Intuitive posted profits of $380.6 million, or $1.04 per share, on sales of $1.6 billion for the three months ended […]

Filed Under: Business/Financial News, Featured, MassDevice Earnings Roundup, News Well, Robotics, Surgical, Wall Street Beat Tagged With: coronavirus, COVID-19, Intuitive Surgical

Markey wants COVID-19 test-makers to lower prices

January 19, 2022 By Chris Newmarker

Sen. Ed Markey, D-Massachusetts, has sent letters to CEOs of at-home COVID-19 test-makers, asking why tests are selling for as much as $12 apiece. In a letter sent today to Abbott CEO Robert Ford, for example, Markey cited a Reuters story from October 2021 in which British test-maker Mologic said that rapid antigen tests can […]

Filed Under: Business/Financial News, Diagnostics, Featured, News Well Tagged With: Abbott, Acon Laboratories, BD, coronavirus, COVID-19, Ellume, Massachusetts, OraSure Technologies Inc., Quidel

  • « Go to Previous Page
  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to page 4
  • Go to page 5
  • Interim pages omitted …
  • Go to page 99
  • Go to Next Page »

Primary Sidebar

DeviceTalks Weekly

July 1, 2022
Boston Scientific CEO Mike Mahoney on building a corporate culture that drives high growth results
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS